NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development

In recent years, cell-based immunotherapies have demonstrated promising results in the treatment of cancer. Chimeric antigen receptors (CARs) arm effector cells with a weapon for targeting tumor antigens, licensing engineered cells to recognize and kill cancer cells. The quality of the CAR-antigen i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashiri Dezfouli, Ali, Yazdi, Mina, Pockley, Alan Graham, Khosravi, Mohammad, Kobold, Sebastian, Wagner, Ernst, Multhoff, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699535/
https://www.ncbi.nlm.nih.gov/pubmed/34943898
http://dx.doi.org/10.3390/cells10123390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699535/
https://www.ncbi.nlm.nih.gov/pubmed/34943898
http://dx.doi.org/10.3390/cells10123390

Ejemplares similares